
New partner, bigger sandbox
Tempus AI is linking arms with the Keck School of Medicine of USC and Keck Medicine of USC in a collaboration meant to speed up AI-driven precision medicine. In plain English: Tempus gets to play in a much bigger clinical sandbox, and USC gets a tech partner that thinks data is the new stethoscope.
Why this matters
The deal is aimed at improving care delivery across more than 1.5 million annual patient visits tied to USC Norris Comprehensive Cancer Center. That’s a lot of patients, a lot of data, and a lot of chances for Tempus to show its AI tools can help doctors make better calls without turning the hospital into a sci-fi set.
The investor angle
For TEM shareholders, partnerships like this are the company’s bread and butter. They help Tempus widen its footprint in oncology and precision medicine while building credibility with major academic health systems — which is the kind of thing that can turn “interesting tech story” into “actual healthcare infrastructure.”
Big picture: Tempus keeps stacking collaborations to prove its AI isn’t just smart on paper, but useful in the messy, very human world of medicine.
